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Copy number variation (CNV) has recently gained considerable interest as a source of genetic variation likely
to play a role in phenotypic diversity and evolution. Much effort has been put into the identification and map-
ping of regions that vary in copy number among seemingly normal individuals in humans and a number of
model organisms, using bioinformatics or hybridization-based methods. These have allowed uncovering
associations between copy number changes and complex diseases in whole-genome association studies,
as well as identify new genomic disorders. At the genome-wide scale, however, the functional impact of
CNV remains poorly studied. Here we review the current catalogs of CNVs, their association with diseases
and how they link genotype and phenotype. We describe initial evidence which revealed that genes in
CNV regions are expressed at lower and more variable levels than genes mapping elsewhere, and also
that CNV not only affects the expression of genes varying in copy number, but also have a global influence
on the transcriptome. Further studies are warranted for complete cataloguing and fine mapping of CNVs, as
well as to elucidate the different mechanisms by which they influence gene expression.
INTRODUCTION
A fundamental question in current biomedical research is to
establish a link between genomic variation and phenotypic
differences, which encompasses both the seemingly neutral
polymorphic variation, as well as the pathological variation
that causes or predisposes to disease. DNA copy number var-
iants, defined as stretches of DNA larger than 1 kb that display
copy number differences in the normal population (1), have
recently gained considerable interest as a source of genetic
diversity likely to play a role in functional variation (2–5).
Extensive studies were performed to establish CNV cata-
logs for multiple species, however little is known about the
functional impact of CNVs at the cellular and organismal
level. Here, we review recent works on the identification of
CNVs, their association with disease and their global impact
on gene expression, as well as discuss possible mechanisms
by which CNVs exert this influence.
COPY NUMBER VARIATION IN HUMAN AND
MODEL ORGANISMS
Whole-genome CNV catalogs have been established for the
human (4,6–8), the mouse (9–16), the rat (17), the chimpanzee
(7,18), the rhesus macaque (19) and Drosophila melanogaster
(20,21) (Table 1). CNVs were identified by array comparative
genome hybridization (aCGH) (22), either with bacterial artifi-
cial chromosome or oligonucleotide probes. Alternatively,
bioinformatics mining of whole genome shotgun (WGS)
sequences was used to predict CNVs in human, macaque and
rat (17,23,24). As observed in humans, distinct array platforms
yielded considerably different datasets with little overlap [43%
and 37% overlap, respectively (4,16)], whereas studies per-
formed using the same platform were shown to be highly repro-
ducible (12,16). Similarly, Guryev et al. (17) found a very good
correspondence between WGS-based predictions and hybridiz-
ation methods. On the other hand, changes in calling methods
were shown to modify the number of CNV predictions, with
methods that congruently analyze aCGH data from multiple
samples significantly increasing the number of detectable
CNVs (14,16).
General characteristics of the CNVs identified in human and
model organisms are summarized in Table 1. Interestingly, the
CNVs reported in D. melanogaster are one order of magnitude
shorter (maximum 33 kb or 0.017% of the fly genome) than
those found in mammals (up to 3 Mb or 0.12% of the mouse
genome). A certain synteny has been observed among pri-
mates with 22% and 25% of chimpanzee and macaque
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CNVs overlapping human CNVs (7,19). In addition, CNVs
identified in multiple macaques were frequently observed in
multiple human samples, suggesting the existence of hotspots
for CNV (19). Indeed, structural genomic rearrangements are
facilitated by repetitive sequences that provide the substrate
for non-allelic homologous recombination (25). Consistently,
CNVs are associated with segmental duplications (SDs)
in mammals (2,4,7,8,11,12,19) and to centromeres and telo-
meres (17,26), structures also associated with SDs. For
example, as much as 60% of the basepairs mapping inside
C57BL/6J SDs were recently shown to be polymorphic
among classical mouse inbred strains (14). In other words,
an average of 20 Mb of DNA is variable in number
of copies between two laboratory mice in these regions.
Similarly, in D. melanogaster, CNVs cluster in regions of
the fly genome enriched in tandem repeats, and over half the
transposons assessed were demonstrated to vary in number
of copies between strains (20).
On the other hand, the lower boundaries of the ranges of
CNV size reflect the resolution of the platforms used, as
well as the power and stringency of the prediction algorithms,
rather than the actual minimal size of CNVs. A complete cat-
aloguing of CNVs and other structural changes in mammals
and other animal models still awaits further analyses with
increased resolution and the advent of different approaches
that take advantage of high-throughput sequencing (27,28).
For example, paired-end sequence tag mapping allows the
detection of smaller structural variants (down to a few kilo-
bases), however, this approach is biased towards small
events, meaning that the different detection techniques
should be used in parallel (28,29).
Several personal genomes from different ethnicity and of
both sexes have been sequenced, each dataset reinforcing the
catalog of variants that exist in human genomes (29–32).
For example, 1.4% of the total sequencing data from the
genome of James Watson does not map with the NCBI36
reference assembly, and 23 new CNV regions were identified
(32). Similarly, 2500 and 5000 structural variants were uncov-
ered in an Asian and an African genome, respectively (29,30),
while Kidd and colleagues (27) found 525 CNV regions in a
sample of four African and four non-African genomes. In
one Asian male, 34% of the structural variants discovered
are novel, and 33 genes were found to be completely or par-
tially disrupted, a change that is homozygous for 30% of
these loci. For example, CYP4F12 on chromosome 19 was
broken in two segments by an inversion (29). This epitomizes
that the sequencing of large numbers of individuals is needed
to fully capture the diversity and complexity of the genome.
The number of polymorphisms of copy numbers identified
in the mouse, the only animal model for which we have accu-
mulated a fair amount of data at the moment, appears to be
similar, if not greater than that reported in human (14,16).
However, this type of variation appears to be far more clus-
tered in discrete regions in this model than in humans, prob-
ably reflecting the unnatural man-driven establishment of
inbred lines. Of note, CNVs and single nucleotide polymorph-
isms (SNPs) cluster in different regions of the domesticated
mouse genome (10,33). Consistently, Cutler et al. (10) found
that CNV segments were significantly enriched among
sequences with low and moderate SNP content. The artificially
repeated brother–sister mating of mice over generations has
eliminated recessive lethal alleles, but may have increased
the fixation of potentially (slightly) deleterious CNV alleles.
Consistently, significantly more CNVs were identified in
classical inbred strains than in wild-caught Mus musculus
domesticus mice (16).
CNV regions are not only polymorphic within a species, but
spontaneous de novo rearrangements can occur even in an
inbred population, as shown by recent studies of the classical
C57BL/6J strain (13,16,34). Egan et al. and Henrichsen et al.
identified and validated 38 and 39 CNVs in this isogenic
strain, respectively, 18 of which occurred through recurrent
mutations (13,16). In addition, a single-copy and a duplication
allele of the CNV spanning the Ide locus were found to be in
Hardy–Weinberg equilibrium 14 years after their appearance
in the Jackson Laboratory colony (34). These findings illus-
trate the highly dynamic nature of CNV regions and challenge
the notion of the isogenicity of inbred strains (35).
Table 1. Genome-wide copy number variation (CNV) surveys in human and model organisms
Model organism Platform Probe
density
Resolution % of genome
covered by CNVs
Size range of CNVs References
Human BAC arrays 1 Mb Up to 2 Mb (2,8)
Human Representational Oligonucleotide
Microarray Analysis (ROMA)
1/17 kb 35 kb 1.49% 700 bp to 3.19 Mb (5)
Human BAC arrays and SNP genotyping arrays 12% Up to 6 Mb (4)
Human Bioinformatics and BAC arrays 8–329 kb (6)
Drosophila Spotted PCR array 1/4.1 kb Up to 33 kb (20)
Drosophila Euchromatic genome tiling array 1/36 bp ,1 kb 2% Up to 35 kb (21)
Mouse BAC arrays 1 Mb (9,11,15)











Rat Bioinformatics and oligonucleotide arrays 1/5 kb 1.4% (17)
Macaque Oligonucleotide arrays 1/6 kb 40 kb 32–710 kb (19)
Chimpanzee Human BAC arrays (2) 1/1 Mb 1 Mb (7)
BAC, bacterial artificial chromosome; PCR, polymerase chain reaction.
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PHENOTYPIC CONSEQUENCES OF CNVS
With their prevalence, e.g. 10% of the mouse autosomal
genome and 60% of its duplicated regions (14,16), CNVs
should constitute significant contributors to intraspecific
genetic variation. Consistently, an initial case of adaptive
CNV alleles under positive selection was recently uncovered
(36). Similarly, copy numbers of individual CNVs have been
associated with diseases or susceptibility to diseases, either
through dosage of a single gene (37–44), a contiguous set
of genes [e.g. Williams-Beuren syndrome and infantile
spasms (45,46), DiGeorge Syndrome (47), Smith-Magenis
syndrome (48), Potocki-Lupski syndrome (49)] or allele com-
binations in the case of complex diseases, especially of the
central nervous system. Recent studies in schizophrenia
(50,51), autism (52,53) and mental retardation (54–56)
revealed multiple disease-causing rearrangements, but also
lead to the description of novel, clinically recognizable micro-
deletion syndromes and recurrent rearrangements causing
variable phenotypes (57–65). Structural rearrangements in
three regions, namely 1q21.1, 15q11.2 and 15q13.3 were
shown to be associated with both mental retardation and
schizophrenia. A more detailed investigation of cases might
shed light on a possible link between these conditions. Inter-
estingly, while deletions at all three loci were linked to schizo-
phrenia and related psychoses (50,51), the maternal
duplication of the entire 15q11-q13 region was shown to
cause autism spectrum disorder (ASD) (66). Similarly, dupli-
cation of band 1q21.1 was identified in patients with ASD,
whereas both deletions and duplications were associated
with mental retardation. These examples suggest that some
conditions might not be associated with a specific number of
copies of a particular CNV, but rather that the simple presence
of a structural change at a given position of the human genome
may cause perturbation in particular pathways regardless of
gene dosage.
CNV has also been shown to induce phenotypes in non-
mammalian vertebrates and in invertebrates. For example,
copy number amplification of regions containing the mannose-
binding lectin and the pfmdr1 and gch1 genes influence the
zebrafish susceptibility to bacterial infection and malaria
parasite Plasmodium falciparum drug resistance, respectively
(67,68).
FROM GENOTYPE TO PHENOTYPE—BRIDGING
THE GAP
Phenotypic effects of genetic differences, both at the single-
nucleotide and large-scale level, are supposedly brought
about by changes in expression levels, either directly affecting
the genes concerned by the genetic change, or indirectly
through position effects or downstream pathways and regulat-
ory networks (69,70). Thus, transcriptome analyses and single-
gene expression studies seem appropriate proxies to study the
consequences of CNV.
A first attempt to estimate the contribution of CNVs to gene
expression variation found that in human lymphoblastoid cell
lines, changes in copy numbers capture about one-fifth of the
detected genetic variation (71). This type of approach,
however, does not allow to follow the influence of CNVs in
multiple tissues nor developmental stages, as an individual
will have been the source of a limited number of cell lines,
typically a skin fibroblast and a lymphoblastoid cell line or,
more rarely, different cell lines from umbilical cord. This dif-
ficulty can be overcome using animal models, as recent ana-
lyses suggest that CNVs are also important contributors to
their phenotypic variation (Table 1). In some cases given
CNVs were shown to cause the same phenotype in a model
organism and in human patients, further exemplifying the val-
idity of models studies. For example, Aitman et al. (40)
showed that lower copy number of the Fcgr3 gene predisposed
both rats and humans to immunologically mediated glomeru-
lonephritis. In addition to natural CNV, structural modifi-
cations can be engineered into model organisms, e.g. mice,
and thus allow the study of different alleles of a CNV, as
well as position effects, in a genetically homogenous back-
ground (72,73).
Two recent reports attempted to assess the effects of CNVs
on tissue transcriptomes of rats and mice (16,17). Both studies
report an over-representation of differentially expressed genes
among CNV-mapping transcripts. Globally, a weak yet signifi-
cant positive correlation was found between relative
expression level and gene dosage (see examples in Fig. 1).
This correlation was driven by a restricted number of genes,
as only a fraction of genes comprised between 5% and 18%
in function of the tissue and the rodent species analyzed
showed a strong correlation between number of copies and
relative expression levels (16,17) (see example in Fig. 1A
and possible mechanism in Fig. 2B). In about two-third of
the genes, however, the number of copies had no effect on
relative expression levels in any tissue (see example in
Fig. 1C), suggesting either dosage compensation mechanisms
or the incomplete inclusion of regulatory elements in the del-
etion/duplication event (see possible mechanisms in Fig. 2). In
addition, genetic imprinting may also modulate the expression
at a CNV locus, in a parental allele-dependent manner (74).
The first hypothesis is supported by the observation that
expression of some genes correlated with gene dosage in
some tissues but not in others (see examples in Fig. 1D and
mechanisms in Fig. 2B and C), whereas the second is sup-
ported by studies of the quantitative collinearity of Hoxd
genes, which showed that their expression levels are correlated
with their rank in the Hoxd cluster (75) (see mechanism in
Fig. 2D). Alternatively, the multiple copies of a gene might
be mapping to different chromatin environments and thus be
regulated differentially (Fig. 2E); indeed, aCGH does not
allow discriminating tandem from non-tandem duplications.
Furthermore, for 2–15% of the genes depending on the
tissue and the rodent assessed, the recorded relative expression
levels were significantly inversely correlated with CNV
(16,17) (see examples in Fig. 1B). The mechanism of this
effect is still poorly understood, but may be explained by
two models summarized in Fig. 2F and 2G. In the first
model, a negative correlation between number of copies and
relative expression is explained by immediate early genes
(IEG, Fig. 2F). These genes are initially expressed at levels
proportional to their number of copies (Fig. 2A and B).
These IEG induce directly or indirectly the expression of a
repressor which, by a negative feedback loop, reduces or
even abolishes the expression of the CNV gene (Fig. 2F).
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In the second hypothesis, the extra copies of a gene impair
through steric hinderance their access to a specific transcrip-
tion factory, where this particular locus should be transcribed
(76) (Fig. 2G).
Genes mapping to CNVs show lower expression levels than
transcripts that do not vary in numbers of copies, both in fly
and mouse (16,20). These observations suggest that CNV
genes might be more specific in their expression patterns
than other genes. In support of this notion, CNV genes were
detectable in a smaller number of tissues than non-CNV
genes both in the mouse and Drosophila (16,20). In addition,
Dopman and Hartl (20) observed that the CNV genes
expressed in the fly midgut and male accessory glands were
enriched for functions relevant to these tissues, defense
response in both cases and post-mating behavior genes in
the latter case.
Large-scale rearrangements do not only affect expression by
altering gene dosage. The deletion associated with Williams-
Beuren syndrome was shown to modify the expression of
some of the normal-copy number neighboring genes in human
lymphoblastoid and skin fibroblast cell lines (77). Consistently,
Stranger et al. (71) observed that although CNVs capture 18%
of the detected genetic variation in lymphoblastoid cell lines,
more than half of the identified associations between copy
numbers and expression levels involved genes mapping
outside the CNV intervals. Likewise, an engineered duplication
of a segment of mouse chromosome 11, that models the
rearrangement present in Potocki-Lupski syndrome patients,
Figure 1. Relative expression levels as a function of relative copy number. Examples of positive correlation [AK002941 gene, 1428989_at probeset; (A)], nega-
tive correlation [BC004065 gene, 1452426_x_at probeset; (B)], absence of correlation [Birc1f gene, 1427434_at probeset; (C)] and multiple trend correlation
[Rshl2a/b gene, 1423119_at probeset; (D)] between relative expression levels and array CGH log2 ratio measured in testis (blue), brain (red), liver (brown),
lung (green), heart (purple) and kidney (orange).
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was shown to affect the expression of both the genes mapping
within the duplicated interval and its flanks (72). Thus, CNVs
also profoundly affect the expression of genes located in their
vicinity. This effect extends over half a megabase into their
genomic neighborhoods (16,17). But how may changes in
copy number of CNV regions alter the expression of genes in
their vicinity? Different CNV-induced mechanisms that
include the physical dissociation of the transcription unit from
its cis-acting regulators (78,79), modification of transcriptional
control through alteration of chromatin structure (80–83) and
modification of the positioning of chromatin within the
nucleus and/or within a chromosome territory of a genomic
region (84,85) might play a role, both individually or in combi-
nation. Copy number changes might also influence gene
expression through perturbation of transcript structure
(70,86,87). Similar mechanisms might explain how some path-
ways are perturbed without correlation with a particular number
of copies of a CNV (see above). Detailed investigations of the
different mechanisms by which CNVs influence gene
expression are warranted to shed light on how CNVs alter the
architecture of chromosomal segments and thus influence the
expression of genes.
CONCLUSION
The identification of CNVs in both human and model organ-
isms and their association with diseases and phenotypes
have confirmed that these genome structural changes are
important contributors to variation. They exert their influence
by modifying the expression of genes mapping within and
close to the rearranged region.
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Figure 2. Duplication scenarios and their influence on expression. (A) Single copy gene locus. The gene intron–exon region (blue box), the gene promoter (red
arrow) and its enhancer (green box) are shown. Transcript levels are indicated schematically on the right. (B) Complete tandem duplication including the regu-
latory region. (C) Complete tandem duplication including the regulatory region of a gene under a compensatory mechanism. A negative feedback loop reduces
the gene transcription level. (D) Complete tandem duplication excluding the regulatory region. The single enhancer only weakly influences expression of the
second copy of the gene, which is expressed at a lower level. (E) Complete non-tandem duplication including the regulatory region. The duplicated locus
maps to another chromosome region where a different chromatin context, e.g. insulators (yellow ellipses), modifies its expression level. (F) Immediate early
gene model. In the presence of a duplication, the concentration of CNV gene product (blue hexagons) is sufficient to induce a repressor (light green box),
the product of which (light green disks) blocks the expression of the CNV gene. (G) A tandem duplication (2) physically impairs the access of the CNV
genes copies to the transcription factory where it should be transcribed (1).
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